57 related articles for article (PubMed ID: 33991070)
1. Prognostic Significance of Glycolysis-Related Genes in Lung Squamous Cell Carcinoma.
Kadasah SF
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256214
[TBL] [Abstract][Full Text] [Related]
2. Identification and prognostic value of a glycolysis-related gene signature in patients with bladder cancer.
Wu Z; Wen Z; Li Z; Yu M; Ye G
Medicine (Baltimore); 2021 Jan; 100(3):e23836. PubMed ID: 33545950
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal transition-related gene signature for prognosis of lung squamous cell carcinoma.
Yu H; Dai C; Li J; Zhang X
Medicine (Baltimore); 2023 Jul; 102(28):e34271. PubMed ID: 37443495
[TBL] [Abstract][Full Text] [Related]
4. The necroptosis signature and molecular mechanism of lung squamous cell carcinoma.
Song GQ; Wu HM; Ji KJ; He TL; Duan YM; Zhang JW; Hu GQ
Aging (Albany NY); 2023 Nov; 15(22):12907-12926. PubMed ID: 37976123
[TBL] [Abstract][Full Text] [Related]
5. Identification of SLC2A1 as a predictive biomarker for survival and response to immunotherapy in lung squamous cell carcinoma.
Hao B; Dong H; Xiong R; Song C; Xu C; Li N; Geng Q
Comput Biol Med; 2024 Mar; 171():108183. PubMed ID: 38422959
[TBL] [Abstract][Full Text] [Related]
6. DNA-PK-Mediated Cytoplasmic DNA Sensing Stimulates Glycolysis to Promote Lung Squamous Cell Carcinoma Malignancy and Chemoresistance.
Wang H; Zhang Y; Tian Y; Yang W; Wang Y; Hou H; Pan H; Pei S; Zhu H; Gu Z; Zhang Y; Dai D; Chen W; Zheng M; Luo Q; Xiao Y; Huang J
Cancer Res; 2024 Mar; 84(5):688-702. PubMed ID: 38199791
[TBL] [Abstract][Full Text] [Related]
7. A four-gene-based methylation signature associated with lymph node metastasis predicts overall survival in lung squamous cell carcinoma.
Deng Y; Liu L; Xiao X; Zhao Y
Genes Genet Syst; 2023 Nov; 98(5):209-219. PubMed ID: 37839873
[TBL] [Abstract][Full Text] [Related]
8. HIF1A-dependent overexpression of MTFP1 promotes lung squamous cell carcinoma development by activating the glycolysis pathway.
Ji J; Wang Y; Jing A; Ma L; Yang J; Ren D; Lv J; Lv M; Xu M; Yuan Q; Ma X; Qian Q; Wang W; Geng T; Ding Y; Qin J; Liu Y; Zhou J; Zuo L; Ma S; Wang X; Liu B
Heliyon; 2024 Apr; 10(7):e28440. PubMed ID: 38689964
[TBL] [Abstract][Full Text] [Related]
9. NPLOC4 is a potential target and a poor prognostic signature in lung squamous cell carcinoma.
Wang N; Zhu D; Liu Y; Wu J; Wang M; Jin S; Fu F; Li B; Ji H; Du C; Zheng Z
Sci Rep; 2023 Nov; 13(1):20430. PubMed ID: 37993584
[TBL] [Abstract][Full Text] [Related]
10. Somatic genome alterations in relation to age in lung squamous cell carcinoma.
Meucci S; Keilholz U; Heim D; Klauschen F; Cacciatore S
Oncotarget; 2018 Aug; 9(63):32161-32172. PubMed ID: 30181806
[TBL] [Abstract][Full Text] [Related]
11. Microbiota modulate lung squamous cell carcinoma lymph node metastasis through microbiota-geneset correlation network.
Liang P; Deng H; Zhao Y; Chen Y; Zhang J; He J; Liang W
Transl Lung Cancer Res; 2023 Nov; 12(11):2245-2259. PubMed ID: 38090530
[TBL] [Abstract][Full Text] [Related]
12. Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung.
Wang Z; Xuan Y; Shao Y; Zou Q; Cui H; Jin X
Comput Intell Neurosci; 2022; 2022():3137370. PubMed ID: 36438688
[TBL] [Abstract][Full Text] [Related]
13. The hexokinase "HKDC1" interaction with the mitochondria is essential for liver cancer progression.
Khan MW; Terry AR; Priyadarshini M; Ilievski V; Farooq Z; Guzman G; Cordoba-Chacon J; Ben-Sahra I; Wicksteed B; Layden BT
Cell Death Dis; 2022 Jul; 13(7):660. PubMed ID: 35902556
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a 7-Gene Inflammatory Signature Forecasts Prognosis and Diverse Immune Landscape in Lung Adenocarcinoma.
Nai A; Ma F; He Z; Zeng S; Bashir S; Song J; Xu M
Front Mol Biosci; 2022; 9():822739. PubMed ID: 35372503
[No Abstract] [Full Text] [Related]
15. Identification of a glycolysis-related gene signature associated with clinical outcome for patients with lung squamous cell carcinoma.
Xu Z; Zhang S; Nian F; Xu S
Cancer Med; 2021 Jun; 10(12):4017-4029. PubMed ID: 33991070
[TBL] [Abstract][Full Text] [Related]
16. A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma.
Huang G; Zhang J; Gong L; Huang Y; Liu D
BMC Cancer; 2021 May; 21(1):626. PubMed ID: 34044809
[TBL] [Abstract][Full Text] [Related]
17. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
Gao X; Wu Y; Yu W; Li H
Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
Diao X; Guo C; Liu L; Wang G; Li S
Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
